Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × tipifarnib × Clear all

Sponsor

Conditions

Leukemia, Myelomonocytic, Acute 3 Leukemia, Myeloid, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Melanoma 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Breast Neoplasms 2 Brain Neoplasms 2 Anemia, Refractory, with Excess of Blasts 2 Wilms Tumor 1 Thyroid Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Pheochromocytoma 1 Osteosarcoma 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡